Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study

Anti-myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) recently emerged as a potential biomarker in patients with inflammatory demyelinating diseases of the central nervous system. We here compare the clinical and laboratory findings observed in a cohort of MOG-Ab seropositive and seronegative...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of neurology Ročník 264; číslo 12; s. 2420 - 2430
Hlavní autori:	Mariotto, Sara, Ferrari, Sergio, Monaco, Salvatore, Benedetti, Maria Donata, Schanda, Kathrin, Alberti, Daniela, Farinazzo, Alessia, Capra, Ruggero, Mancinelli, Chiara, De Rossi, Nicola, Bombardi, Roberto, Zuliani, Luigi, Zoccarato, Marco, Tanel, Raffaella, Bonora, Adriana, Turatti, Marco, Calabrese, Massimiliano, Polo, Alberto, Pavone, Antonino, Grazian, Luisa, Sechi, GianPietro, Sechi, Elia, Urso, Daniele, Delogu, Rachele, Janes, Francesco, Deotto, Luciano, Cadaldini, Morena, Bianchi, Maria Rachele, Cantalupo, Gaetano, Reindl, Markus, Gajofatto, Alberto
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2017 Springer Nature B.V
Predmet:	Aquaporin 4 Central nervous system Demyelinating diseases Demyelination Glycoproteins Immunofluorescence Immunoglobulin G Immunoglobulins Laboratories Magnetic resonance imaging Medicine Medicine & Public Health Myelin Neurology Neuroradiology Neurosciences Oligodendrocyte-myelin glycoprotein Optic nerve Original Communication Spinal cord Myelitis Neuromyelitis optica spectrum disorders (NMOSD) Acute disseminated encephalomyelitis (ADEM) Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies Multiple sclerosis (MS) Optic neuritis
ISSN:	0340-5354, 1432-1459, 1432-1459
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Anti-myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) recently emerged as a potential biomarker in patients with inflammatory demyelinating diseases of the central nervous system. We here compare the clinical and laboratory findings observed in a cohort of MOG-Ab seropositive and seronegative cases and describe IgG subclass analysis results. Consecutive serum samples referred to Verona University Neuropathology Laboratory for aquaporin-4 (AQP4)-Ab and/or MOG-Ab testing were analysed between March 2014 and May 2017. The presence of AQP4-Ab was determined using a cell-based assay. A live cell immunofluorescence assay was used for the detection of MOG-IgG and IgG subclass analysis. Among 454 analysed samples, 29 were excluded due to AQP4-Ab positivity or to the final demonstration of a disorder not compatible with MOG-Ab. We obtained clinical data in 154 out of 425 cases. Of these, 22 subjects resulted MOG-Ab positive. MOG-Ab positive patients were mainly characterised by the involvement of the optic nerve and/or spinal cord. Half of the cases presented relapses and the recovery was usually partial. Brain MRI was heterogeneous while short lesions were the prevalent observation on spinal cord MRI. MOG-Ab titre usually decreased in non-relapsing cases. In all MOG-IgG positive cases, we observed IgG1 antibodies, which were predominant in most subjects. IgG2 (5/22), IgG3 (9/22) and IgG4 (3/22) antibodies were also detectable. We confirm that MOG-Ab-related syndromes have distinct features in the spectrum of demyelinating conditions, and we describe the possible role of the different IgG subclasses in this condition.
AbstractList	Anti-myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) recently emerged as a potential biomarker in patients with inflammatory demyelinating diseases of the central nervous system. We here compare the clinical and laboratory findings observed in a cohort of MOG-Ab seropositive and seronegative cases and describe IgG subclass analysis results. Consecutive serum samples referred to Verona University Neuropathology Laboratory for aquaporin-4 (AQP4)-Ab and/or MOG-Ab testing were analysed between March 2014 and May 2017. The presence of AQP4-Ab was determined using a cell-based assay. A live cell immunofluorescence assay was used for the detection of MOG-IgG and IgG subclass analysis. Among 454 analysed samples, 29 were excluded due to AQP4-Ab positivity or to the final demonstration of a disorder not compatible with MOG-Ab. We obtained clinical data in 154 out of 425 cases. Of these, 22 subjects resulted MOG-Ab positive. MOG-Ab positive patients were mainly characterised by the involvement of the optic nerve and/or spinal cord. Half of the cases presented relapses and the recovery was usually partial. Brain MRI was heterogeneous while short lesions were the prevalent observation on spinal cord MRI. MOG-Ab titre usually decreased in non-relapsing cases. In all MOG-IgG positive cases, we observed IgG1 antibodies, which were predominant in most subjects. IgG2 (5/22), IgG3 (9/22) and IgG4 (3/22) antibodies were also detectable. We confirm that MOG-Ab-related syndromes have distinct features in the spectrum of demyelinating conditions, and we describe the possible role of the different IgG subclasses in this condition.Anti-myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) recently emerged as a potential biomarker in patients with inflammatory demyelinating diseases of the central nervous system. We here compare the clinical and laboratory findings observed in a cohort of MOG-Ab seropositive and seronegative cases and describe IgG subclass analysis results. Consecutive serum samples referred to Verona University Neuropathology Laboratory for aquaporin-4 (AQP4)-Ab and/or MOG-Ab testing were analysed between March 2014 and May 2017. The presence of AQP4-Ab was determined using a cell-based assay. A live cell immunofluorescence assay was used for the detection of MOG-IgG and IgG subclass analysis. Among 454 analysed samples, 29 were excluded due to AQP4-Ab positivity or to the final demonstration of a disorder not compatible with MOG-Ab. We obtained clinical data in 154 out of 425 cases. Of these, 22 subjects resulted MOG-Ab positive. MOG-Ab positive patients were mainly characterised by the involvement of the optic nerve and/or spinal cord. Half of the cases presented relapses and the recovery was usually partial. Brain MRI was heterogeneous while short lesions were the prevalent observation on spinal cord MRI. MOG-Ab titre usually decreased in non-relapsing cases. In all MOG-IgG positive cases, we observed IgG1 antibodies, which were predominant in most subjects. IgG2 (5/22), IgG3 (9/22) and IgG4 (3/22) antibodies were also detectable. We confirm that MOG-Ab-related syndromes have distinct features in the spectrum of demyelinating conditions, and we describe the possible role of the different IgG subclasses in this condition. Anti-myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) recently emerged as a potential biomarker in patients with inflammatory demyelinating diseases of the central nervous system. We here compare the clinical and laboratory findings observed in a cohort of MOG-Ab seropositive and seronegative cases and describe IgG subclass analysis results. Consecutive serum samples referred to Verona University Neuropathology Laboratory for aquaporin-4 (AQP4)-Ab and/or MOG-Ab testing were analysed between March 2014 and May 2017. The presence of AQP4-Ab was determined using a cell-based assay. A live cell immunofluorescence assay was used for the detection of MOG-IgG and IgG subclass analysis. Among 454 analysed samples, 29 were excluded due to AQP4-Ab positivity or to the final demonstration of a disorder not compatible with MOG-Ab. We obtained clinical data in 154 out of 425 cases. Of these, 22 subjects resulted MOG-Ab positive. MOG-Ab positive patients were mainly characterised by the involvement of the optic nerve and/or spinal cord. Half of the cases presented relapses and the recovery was usually partial. Brain MRI was heterogeneous while short lesions were the prevalent observation on spinal cord MRI. MOG-Ab titre usually decreased in non-relapsing cases. In all MOG-IgG positive cases, we observed IgG1 antibodies, which were predominant in most subjects. IgG2 (5/22), IgG3 (9/22) and IgG4 (3/22) antibodies were also detectable. We confirm that MOG-Ab-related syndromes have distinct features in the spectrum of demyelinating conditions, and we describe the possible role of the different IgG subclasses in this condition.
Author	Polo, Alberto Sechi, GianPietro Deotto, Luciano Monaco, Salvatore Gajofatto, Alberto Bianchi, Maria Rachele Tanel, Raffaella Zuliani, Luigi Schanda, Kathrin Mancinelli, Chiara Zoccarato, Marco Turatti, Marco Delogu, Rachele Ferrari, Sergio Bombardi, Roberto Bonora, Adriana Urso, Daniele Grazian, Luisa De Rossi, Nicola Mariotto, Sara Pavone, Antonino Farinazzo, Alessia Reindl, Markus Calabrese, Massimiliano Janes, Francesco Benedetti, Maria Donata Cadaldini, Morena Alberti, Daniela Capra, Ruggero Cantalupo, Gaetano Sechi, Elia
Author_xml	– sequence: 1 givenname: Sara orcidid: 0000-0002-7806-3103 surname: Mariotto fullname: Mariotto, Sara email: sara.mariotto@gmail.com organization: Department of Neuroscience, Biomedicine and Movement Sciences, Neurology Unit, University of Verona, Clinical Department of Neurology, Medical University of Innsbruck – sequence: 2 givenname: Sergio surname: Ferrari fullname: Ferrari, Sergio organization: Department of Neuroscience, Biomedicine and Movement Sciences, Neurology Unit, University of Verona – sequence: 3 givenname: Salvatore surname: Monaco fullname: Monaco, Salvatore organization: Department of Neuroscience, Biomedicine and Movement Sciences, Neurology Unit, University of Verona – sequence: 4 givenname: Maria Donata surname: Benedetti fullname: Benedetti, Maria Donata organization: Department of Neuroscience, Biomedicine and Movement Sciences, Neurology Unit, University of Verona – sequence: 5 givenname: Kathrin surname: Schanda fullname: Schanda, Kathrin organization: Clinical Department of Neurology, Medical University of Innsbruck – sequence: 6 givenname: Daniela surname: Alberti fullname: Alberti, Daniela organization: Department of Neuroscience, Biomedicine and Movement Sciences, Neurology Unit, University of Verona – sequence: 7 givenname: Alessia surname: Farinazzo fullname: Farinazzo, Alessia organization: Department of Neuroscience, Biomedicine and Movement Sciences, Neurology Unit, University of Verona – sequence: 8 givenname: Ruggero surname: Capra fullname: Capra, Ruggero organization: Multiple Sclerosis Centre, Spedali Civili of Brescia – sequence: 9 givenname: Chiara surname: Mancinelli fullname: Mancinelli, Chiara organization: Multiple Sclerosis Centre, Spedali Civili of Brescia – sequence: 10 givenname: Nicola surname: De Rossi fullname: De Rossi, Nicola organization: Multiple Sclerosis Centre, Spedali Civili of Brescia – sequence: 11 givenname: Roberto surname: Bombardi fullname: Bombardi, Roberto organization: Neurology Unit, St Bassano Hospital – sequence: 12 givenname: Luigi surname: Zuliani fullname: Zuliani, Luigi organization: Neurology Unit, ULSS 2 Marca Trevigiana, Ca’ Foncello Hospital – sequence: 13 givenname: Marco surname: Zoccarato fullname: Zoccarato, Marco organization: Neurology Unit, O.S.A – sequence: 14 givenname: Raffaella surname: Tanel fullname: Tanel, Raffaella organization: Neurology Unit, S. Chiara Hospital – sequence: 15 givenname: Adriana surname: Bonora fullname: Bonora, Adriana organization: Ophthalmology Unit, AOUI Verona – sequence: 16 givenname: Marco surname: Turatti fullname: Turatti, Marco organization: Department of Neuroscience, Biomedicine and Movement Sciences, Neurology Unit, University of Verona – sequence: 17 givenname: Massimiliano surname: Calabrese fullname: Calabrese, Massimiliano organization: Department of Neuroscience, Biomedicine and Movement Sciences, Neurology Unit, University of Verona – sequence: 18 givenname: Alberto surname: Polo fullname: Polo, Alberto organization: Neurology Unit, Mater Salutis Hospital – sequence: 19 givenname: Antonino surname: Pavone fullname: Pavone, Antonino organization: Neurology Unit, Garibaldi Hospital – sequence: 20 givenname: Luisa surname: Grazian fullname: Grazian, Luisa organization: Pediatric Unit, ULSS 2 Marca Trevigiana, Ca’ Foncello Hospital – sequence: 21 givenname: GianPietro surname: Sechi fullname: Sechi, GianPietro organization: Neurology Unit, Department of Clinical and Experimental Medicine, University of Sassari – sequence: 22 givenname: Elia surname: Sechi fullname: Sechi, Elia organization: Neurology Unit, Department of Clinical and Experimental Medicine, University of Sassari – sequence: 23 givenname: Daniele surname: Urso fullname: Urso, Daniele organization: Neurology Unit, Department of Clinical and Experimental Medicine, University of Sassari – sequence: 24 givenname: Rachele surname: Delogu fullname: Delogu, Rachele organization: Neurology Unit, Department of Clinical and Experimental Medicine, University of Sassari – sequence: 25 givenname: Francesco surname: Janes fullname: Janes, Francesco organization: Neurology Unit, Department of Neuroscience, ASUIUD – sequence: 26 givenname: Luciano surname: Deotto fullname: Deotto, Luciano organization: Neurology A Unit, AOUI Verona – sequence: 27 givenname: Morena surname: Cadaldini fullname: Cadaldini, Morena organization: Multiple Sclerosis Centre of Este – sequence: 28 givenname: Maria Rachele surname: Bianchi fullname: Bianchi, Maria Rachele organization: Neurology Unit, AAS2 Bassa Friulana-Isontina – sequence: 29 givenname: Gaetano surname: Cantalupo fullname: Cantalupo, Gaetano organization: Child Neurology, University of Verona – sequence: 30 givenname: Markus surname: Reindl fullname: Reindl, Markus organization: Clinical Department of Neurology, Medical University of Innsbruck – sequence: 31 givenname: Alberto surname: Gajofatto fullname: Gajofatto, Alberto organization: Department of Neuroscience, Biomedicine and Movement Sciences, Neurology Unit, University of Verona
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/29063242$$D View this record in MEDLINE/PubMed
BookMark	eNp9kk9rFTEUxYNU7Gv1A7iRgBs3ozf_5o8LQR5tLRTc6DrkZe48UzKTZ5IpzFfwU5vhtVILukq493cOh-SckZMpTEjIawbvGUDzIQFIpipgTdXWQlXyGdkwKXjFpOpOyAaEhEoJJU_JWUq3ANCWxQtyyjuoBZd8Q35tvZucNZ6mA9oc55GaqafX-yua5p31JqUyMH5JLtEwlHt21bhgUdHg3T70OPUx2CUj3fvFhkMMGctyBXehX6riEKwzGXualpUdMX2kho6zz87ilDHSlOd-eUmeD8YnfHV_npPvlxfftl-qm69X19vPN5VVos6VavnQYAdWNjVXAoEBrxvBh74GjqzvzCAEmt5CmbHWdjtVA6hmZ1rDQShxTj4dfQ_zbsR-jRCN14foRhMXHYzTf28m90Pvw51WddtyJorBu3uDGH7OmLIeXbLovZkwzEmzTiloBIgVffsEvQ1zLO-5UrWUspOsK9Sbx4n-RHn4pgI0R8DGkFLEQVuXTXZhDei8ZqDXQuhjIXQphF4LoWVRsifKB_P_afhRkwo77TE-Cv1P0W_bbMqw
CitedBy_id	crossref_primary_10_1016_j_neuint_2018_04_009 crossref_primary_10_1016_j_msard_2022_103884 crossref_primary_10_3390_jcm14072445 crossref_primary_10_4103_0028_3886_359209 crossref_primary_10_1016_j_msard_2022_104214 crossref_primary_10_3389_fneur_2022_866824 crossref_primary_10_1016_j_jocn_2021_09_035 crossref_primary_10_1007_s00415_020_10024_0 crossref_primary_10_1016_j_jns_2024_123311 crossref_primary_10_1038_s41582_018_0112_x crossref_primary_10_23736_S1825_859X_22_00154_2 crossref_primary_10_1016_j_msard_2021_102833 crossref_primary_10_1016_j_jneuroim_2020_577260 crossref_primary_10_1007_s00415_024_12438_6 crossref_primary_10_1111_ceo_13863 crossref_primary_10_3389_fimmu_2022_853891 crossref_primary_10_1002_jdn_10106 crossref_primary_10_1212_CPJ_0000000000001129 crossref_primary_10_1016_j_msard_2018_07_026 crossref_primary_10_1016_j_msard_2018_07_025 crossref_primary_10_17116_jnevro202312311147 crossref_primary_10_1111_ene_15304 crossref_primary_10_1177_1756286418762083 crossref_primary_10_1155_2022_4951491 crossref_primary_10_1016_j_jneuroim_2022_577939 crossref_primary_10_1016_j_msard_2020_102428 crossref_primary_10_1016_j_smim_2025_101944 crossref_primary_10_1016_j_msard_2021_102837 crossref_primary_10_1016_S1474_4422_22_00431_8 crossref_primary_10_3389_fimmu_2022_1037812 crossref_primary_10_1007_s11940_021_00667_3 crossref_primary_10_1097_ICU_0000000000000520 crossref_primary_10_1007_s00415_020_10026_y crossref_primary_10_3389_fimmu_2021_752557 crossref_primary_10_1016_j_msard_2019_01_021 crossref_primary_10_1016_j_jneuroim_2022_577933 crossref_primary_10_1016_j_msard_2022_104160 crossref_primary_10_1016_j_msard_2021_103020 crossref_primary_10_1016_j_neurad_2019_06_001 crossref_primary_10_1212_NXI_0000000000000674 crossref_primary_10_1515_cclm_2020_1037 crossref_primary_10_36927_2079_0325_V29_is2_2021_15 crossref_primary_10_4103_aian_AIAN_627_19 crossref_primary_10_1097_WCO_0000000000000681 crossref_primary_10_1177_1756286420945135 crossref_primary_10_1016_j_msard_2018_09_010 crossref_primary_10_1212_WNL_0000000000201662 crossref_primary_10_1111_cei_13641 crossref_primary_10_1007_s13760_021_01712_3 crossref_primary_10_1080_14737175_2020_1764352 crossref_primary_10_3389_fneur_2023_1193211 crossref_primary_10_1038_s41572_020_0214_9 crossref_primary_10_1001_jamanetworkopen_2021_28871 crossref_primary_10_1016_j_jns_2020_117225 crossref_primary_10_1212_NXI_0000000000200293 crossref_primary_10_1080_14737175_2021_1982697 crossref_primary_10_1111_cns_13461 crossref_primary_10_1016_j_autrev_2021_102921 crossref_primary_10_3389_fimmu_2023_1149987 crossref_primary_10_1111_ene_14089 crossref_primary_10_1007_s13760_025_02718_x crossref_primary_10_1016_S1474_4422_20_30432_4 crossref_primary_10_3390_antib13020043 crossref_primary_10_1212_NXI_0000000000200188 crossref_primary_10_1007_s00330_019_06506_z crossref_primary_10_1016_j_braindev_2025_104389 crossref_primary_10_1212_NXI_0000000000200183 crossref_primary_10_3389_fimmu_2018_02753 crossref_primary_10_1212_NXI_0000000000200340 crossref_primary_10_3389_fneur_2025_1619479 crossref_primary_10_1007_s12264_019_00375_8 crossref_primary_10_1016_j_msard_2022_104097 crossref_primary_10_1016_j_msard_2025_106394 crossref_primary_10_1007_s10072_020_04892_7 crossref_primary_10_1007_s11940_021_00672_6 crossref_primary_10_1136_jnnp_2022_330237 crossref_primary_10_1177_1352458519893093 crossref_primary_10_1177_13524585221093789 crossref_primary_10_1155_2018_8487471 crossref_primary_10_1111_ene_14654 crossref_primary_10_1007_s00415_024_12213_7 crossref_primary_10_1186_s41983_022_00496_4 crossref_primary_10_1007_s00115_018_0607_0 crossref_primary_10_1186_s12883_024_03617_z crossref_primary_10_1007_s00415_024_12285_5 crossref_primary_10_1016_j_msard_2020_102468 crossref_primary_10_1016_j_ajo_2020_07_008 crossref_primary_10_1097_WNO_0000000000001772 crossref_primary_10_1017_neu_2021_29 crossref_primary_10_1186_s12974_018_1144_2 crossref_primary_10_3389_fneur_2022_912050 crossref_primary_10_1111_cen3_12564 crossref_primary_10_1016_j_jns_2020_116673 crossref_primary_10_1007_s10072_020_04828_1 crossref_primary_10_1016_j_jneuroim_2019_05_001 crossref_primary_10_1016_j_ebiom_2019_08_052 crossref_primary_10_1111_jpc_16491 crossref_primary_10_1136_jnnp_2018_320287 crossref_primary_10_3390_microorganisms11122902 crossref_primary_10_1177_13524585241298065 crossref_primary_10_1007_s00415_018_9122_2 crossref_primary_10_3389_fnagi_2022_850743 crossref_primary_10_3390_ijms22157925 crossref_primary_10_1177_1352458518776584 crossref_primary_10_3389_fimmu_2018_01169 crossref_primary_10_1016_j_msard_2020_102011 crossref_primary_10_1016_j_neurol_2020_06_016 crossref_primary_10_1016_j_nerep_2022_100073 crossref_primary_10_1016_j_msard_2020_102082 crossref_primary_10_1177_20552173211022767 crossref_primary_10_1212_WNL_0000000000008479 crossref_primary_10_3389_fneur_2021_711376 crossref_primary_10_1007_s00401_020_02132_y crossref_primary_10_1002_cti2_1316 crossref_primary_10_1016_j_jneuroim_2019_577110 crossref_primary_10_3389_fimmu_2021_686466 crossref_primary_10_1016_j_radcr_2024_08_032 crossref_primary_10_3389_fneur_2022_885218 crossref_primary_10_1212_WNL_0000000000012175 crossref_primary_10_3389_fneur_2023_1187824 crossref_primary_10_1007_s11910_024_01344_z crossref_primary_10_1016_j_seizure_2021_09_011 crossref_primary_10_1016_j_jneuroim_2022_577875 crossref_primary_10_1016_j_msard_2021_103191
Cites_doi	10.1093/brain/awg045 10.1016/S0140-6736(04)17551-X 10.1212/NXI.0000000000000012 10.1212/NXI.0000000000000089 10.1212/WNL.0000000000000560 10.1177/1352458513484547 10.1212/NXI.0000000000000040 10.1136/jnnp-2015-312676 10.1016/j.autrev.2014.01.009 10.1111/j.1365-2249.2008.03834.x 10.1177/1352458515593406 10.1212/WNL.0b013e31826aac4e 10.1212/WNL.0b013e318296e917 10.1212/NXI.0000000000000257 10.1055/s-0036-1583184 10.1136/jnnp.57.8.897 10.1038/nrneurol.2010.72 10.1007/s11427-015-4997-y 10.1007/s00415-015-7983-1 10.1093/brain/aww350 10.1002/ana.21916 10.1111/ene.12898 10.1136/jnnp-2015-311743 10.1186/s12974-015-0256-1 10.4049/jimmunol.0801888 10.1212/WNL.0000000000000101 10.1002/acn3.164 10.1001/archneurol.2011.2956 10.1177/1352458515591071 10.1177/1352458514555785 10.1007/s00415-016-8147-7 10.1212/WNL.0b013e318228c0b1 10.1002/ana.22366 10.1097/WCO.0000000000000446 10.1016/j.autrev.2015.12.004 10.1177/1352458516631038 10.1212/NXI.0000000000000131 10.1212/NXI.0000000000000163 10.1186/s12974-016-0717-1 10.1186/1742-2094-8-184 10.1177/1352458512470310 10.1186/s12974-016-0718-0 10.1111/ene.13315 10.1212/WNL.0b013e3182a6cb5c 10.1212/WNL.0000000000004117 10.1212/WNL.0b013e318248dec1 10.1016/j.clim.2010.11.013 10.1212/WNL.0000000000001729 10.1177/1352458515614093 10.1212/NXI.0000000000000062 10.1084/jem.20050304 10.1177/1352458515587751 10.1073/pnas.0607242103 10.1001/jamaneurol.2013.5857 10.1007/s00415-017-8583-z 10.1212/WNL.0000000000004312 10.1136/jnnp-2017-315998
ContentType	Journal Article
Copyright	The Author(s) 2017 Journal of Neurology is a copyright of Springer, (2017). All Rights Reserved.
Copyright_xml	– notice: The Author(s) 2017 – notice: Journal of Neurology is a copyright of Springer, (2017). All Rights Reserved.
DBID	C6C AAYXX CITATION NPM 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM
DOI	10.1007/s00415-017-8635-4
DatabaseName	Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic PubMed ProQuest One Academic Middle East (New)
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1432-1459
EndPage	2430
ExternalDocumentID	PMC5688213 29063242 10_1007_s00415_017_8635_4
Genre	Journal Article
GrantInformation_xml	– fundername: Austrian Research promotion Agency FFG, Bridge 1 grantid: 853209 EDNA – fundername: Austrian Federal Ministry of Science and Economy grantid: grant BIG WIG MS – fundername: European Academy of Neurology grantid: research fellowship – fundername: ; grantid: research fellowship – fundername: ; grantid: grant BIG WIG MS – fundername: ; grantid: 853209 EDNA
GroupedDBID	--- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3SX 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 X7M YLTOR Z45 Z7U Z81 Z82 Z83 Z87 Z8O Z8U Z8V Z8W Z91 Z92 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY NPM 7TK 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 5PM
ID	FETCH-LOGICAL-c536t-582f7e90c476253e01026732fd602e1d9af33eadc032f18c9b560057ba8a20353
IEDL.DBID	RSV
ISICitedReferencesCount	131
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000415632900009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0340-5354 1432-1459
IngestDate	Tue Nov 04 01:57:45 EST 2025 Sun Nov 09 11:23:34 EST 2025 Tue Nov 04 22:09:44 EST 2025 Mon Jul 21 05:57:46 EDT 2025 Sat Nov 29 02:48:26 EST 2025 Tue Nov 18 22:36:11 EST 2025 Fri Feb 21 02:41:43 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	12
Keywords	Myelitis Neuromyelitis optica spectrum disorders (NMOSD) Acute disseminated encephalomyelitis (ADEM) Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies Multiple sclerosis (MS) Optic neuritis
Language	English
License	Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c536t-582f7e90c476253e01026732fd602e1d9af33eadc032f18c9b560057ba8a20353
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-7806-3103
OpenAccessLink	https://link.springer.com/10.1007/s00415-017-8635-4
PMID	29063242
PQID	1964449419
PQPubID	47196
PageCount	11
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_5688213 proquest_miscellaneous_1955073033 proquest_journals_1964449419 pubmed_primary_29063242 crossref_citationtrail_10_1007_s00415_017_8635_4 crossref_primary_10_1007_s00415_017_8635_4 springer_journals_10_1007_s00415_017_8635_4
PublicationCentury	2000
PublicationDate	2017-12-01
PublicationDateYYYYMMDD	2017-12-01
PublicationDate_xml	– month: 12 year: 2017 text: 2017-12-01 day: 01
PublicationDecade	2010
PublicationPlace	Berlin/Heidelberg
PublicationPlace_xml	– name: Berlin/Heidelberg – name: Germany – name: Heidelberg
PublicationTitle	Journal of neurology
PublicationTitleAbbrev	J Neurol
PublicationTitleAlternate	J Neurol
PublicationYear	2017
Publisher	Springer Berlin Heidelberg Springer Nature B.V
Publisher_xml	– name: Springer Berlin Heidelberg – name: Springer Nature B.V
References	Lechner, Baumann, Hennes (CR28) 2016; 87 Ercolini, Miller (CR42) 2009; 155 Mader, Gredler, Schanda (CR12) 2011; 8 Zhou, Srivastava, Nessler (CR14) 2006; 103 Cobo-Calvo, Ruiz, D’Indy (CR49) 2017 Hacohen, Mankad, Chong (CR31) 2017; 89 Brilot, Dale, Selter (CR8) 2009; 66 Yan, Li, Fu (CR23) 2016; 59 Waters, Woodhall, O’Connor (CR19) 2015; 2 Di Pauli, Mader, Rostasy (CR40) 2011; 138 Zamvil, Slavin (CR53) 2015; 2 Lennon, Wingerchuk, Kryzer (CR1) 2004; 364 Marignier, Bernard-Valnet, Giraudon (CR6) 2013; 80 Andersson, Bernardi (CR39) 1994; 57 Cobo-Calvo, Sepúlveda, Bernard-Valnet, Ruiz, Brassat, Martínez-Yélamos, Saiz, Marignier (CR47) 2016; 22 Waters, McKeon, Leite (CR5) 2012; 78 Pandit, Sato, Mustafa (CR41) 2016; 2 Rostasy, Mader, Schanda (CR9) 2012; 69 Fernandez-Carbonell, Vargas-Lowy, Musallam, Healy, McLaughlin, Wucherpfennig, Chitnis (CR21) 2016; 22 Spadaro, Gerdes, Krumbholz (CR27) 2016; 3 Jarius, Ruprecht, Kleiter (CR29) 2016; 13 Deschamps, Lecler, Lamirel (CR32) 2017; 24 Piccolo, Woodhall, Tackley (CR48) 2016; 263 Kaneko, Sato, Nakashima (CR52) 2016; 87 Kitley, Waters, Woodhall (CR16) 2014; 71 Rostásy, Mader, Hennes (CR56) 2013; 19 Ramanathan, Reddel, Henderson (CR43) 2014; 1 Ramanathan, Prelog, Barnes (CR44) 2016; 22 Wingerchuk, Banwell, Bennett (CR7) 2015; 85 Kitley, Woodhall, Waters (CR15) 2012; 79 Polman, Reingold, Banwell (CR34) 2011; 69 Dale, Tantsis, Merheb (CR58) 2014; 1 Thulasirajah, Pohl, Davila-Acosta, Venkateswaran (CR51) 2016; 47 Pröbstel, Dornmair, Bittner (CR13) 2011; 77 Spadaro, Gerdes, Mayer (CR18) 2015; 2 Jurynczyk, Geraldes, Probert (CR55) 2017; 140 Krupp, Tardieu, Amato (CR38) 2013; 19 McLaughlin, Chitnis, Newcombe (CR10) 2009; 183 Petzold, Plant (CR37) 2014; 13 Kim, Woodhall, Kim (CR54) 2015; 2 Chalmoukou, Alexopoulos, Akrivou, Stathopoulos, Reindl, Dalakas (CR46) 2015; 2 Jiao, Fryer, Lennon (CR4) 2013; 81 Jarius, Wildemann (CR3) 2010; 6 Kidd, Burton, Plant, Graham (CR36) 2003; 126 Ramanathan, Dale, Brilot (CR45) 2016; 15 Pröbstel, Rudolf, Dornmair (CR20) 2015; 12 Baumann, Hennes, Schanda (CR22) 2016; 22 Hyun, Woodhall, Kim (CR50) 2017 Hennes, Baumann, Schanda (CR11) 2017 Reindl, Jarius, Rostasy, Berger (CR33) 2017; 30 Höftberger, Sepulveda, Armangue (CR57) 2015; 21 Lennon, Kryzer, Pittock, Verkman, Hinson (CR2) 2005; 202 van Pelt, Wong, Ketelslegers, Hamann, Hintzen (CR24) 2016; 23 Siritho, Sato, Kaneko, Fujihara, Prayoonwiwat (CR25) 2016; 22 Jarius, Ruprecht, Kleiter (CR30) 2016; 13 Sato, Callegaro, Lana-Peixoto (CR17) 2014; 82 Sepúlveda, Armangue, Martinez-Hernandez (CR26) 2016; 263 Lublin, Reingold, Cohen (CR35) 2014; 83 S Jarius (8635_CR3) 2010; 6 S Ramanathan (8635_CR44) 2016; 22 SS Zamvil (8635_CR53) 2015; 2 J Kitley (8635_CR16) 2014; 71 M Andersson (8635_CR39) 1994; 57 Y Jiao (8635_CR4) 2013; 81 Y Yan (8635_CR23) 2016; 59 M Spadaro (8635_CR27) 2016; 3 CH Polman (8635_CR34) 2011; 69 FD Lublin (8635_CR35) 2014; 83 AK Pröbstel (8635_CR20) 2015; 12 VA Lennon (8635_CR1) 2004; 364 M Sepúlveda (8635_CR26) 2016; 263 S Jarius (8635_CR30) 2016; 13 AK Pröbstel (8635_CR13) 2011; 77 R Deschamps (8635_CR32) 2017; 24 S Thulasirajah (8635_CR51) 2016; 47 EM Hennes (8635_CR11) 2017 S Siritho (8635_CR25) 2016; 22 K Chalmoukou (8635_CR46) 2015; 2 F Brilot (8635_CR8) 2009; 66 S Mader (8635_CR12) 2011; 8 L Pandit (8635_CR41) 2016; 2 C Fernandez-Carbonell (8635_CR21) 2016; 22 VA Lennon (8635_CR2) 2005; 202 P Waters (8635_CR19) 2015; 2 M Baumann (8635_CR22) 2016; 22 AM Ercolini (8635_CR42) 2009; 155 PJ Waters (8635_CR5) 2012; 78 M Spadaro (8635_CR18) 2015; 2 Y Hacohen (8635_CR31) 2017; 89 L Piccolo (8635_CR48) 2016; 263 F Pauli Di (8635_CR40) 2011; 138 ED Pelt van (8635_CR24) 2016; 23 S Ramanathan (8635_CR45) 2016; 15 J Kitley (8635_CR15) 2012; 79 K Kaneko (8635_CR52) 2016; 87 R Marignier (8635_CR6) 2013; 80 D Zhou (8635_CR14) 2006; 103 D Kidd (8635_CR36) 2003; 126 K Rostásy (8635_CR56) 2013; 19 A Petzold (8635_CR37) 2014; 13 Á Cobo-Calvo (8635_CR49) 2017 RC Dale (8635_CR58) 2014; 1 C Lechner (8635_CR28) 2016; 87 S Ramanathan (8635_CR43) 2014; 1 Á Cobo-Calvo (8635_CR47) 2016; 22 DK Sato (8635_CR17) 2014; 82 LB Krupp (8635_CR38) 2013; 19 SM Kim (8635_CR54) 2015; 2 M Reindl (8635_CR33) 2017; 30 S Jarius (8635_CR29) 2016; 13 M Jurynczyk (8635_CR55) 2017; 140 KA McLaughlin (8635_CR10) 2009; 183 K Rostasy (8635_CR9) 2012; 69 R Höftberger (8635_CR57) 2015; 21 DM Wingerchuk (8635_CR7) 2015; 85 JW Hyun (8635_CR50) 2017 20639914 - Nat Rev Neurol. 2010 Jul;6(7):383-92 15589308 - Lancet. 2004 Dec 11-17;364(9451):2106-12 28768844 - Neurology. 2017 Aug 29;89(9):900-908 20033986 - Ann Neurol. 2009 Dec;66(6):833-42 25344373 - Mult Scler. 2015 Jun;21(7):866-874 22371853 - Arch Neurol. 2012 Jun;69(6):752-6 22204662 - J Neuroinflammation. 2011 Dec 28;8:184 28248700 - Curr Opin Neurol. 2017 Jun;30(3):295-301 27788675 - J Neuroinflammation. 2016 Sep 26;13(1):279 25821844 - Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e89 26163068 - Mult Scler. 2016 Apr;22(4):470-82 17142321 - Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19057-62 21795651 - Neurology. 2011 Aug 9;77(6):580-8 28477397 - Eur J Neurol. 2017 Jun;24(6):875-879 28607742 - Mult Scler J Exp Transl Clin. 2016 Oct 24;2:2055217316675634 26645082 - J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):897-905 25815356 - Ann Clin Transl Neurol. 2015 Mar;2(3):295-301 24415568 - Neurology. 2014 Feb 11;82(6):474-81 25635259 - Neurol Neuroimmunol Neuroinflamm. 2015 Jan 22;2(1):e62 16087714 - J Exp Med. 2005 Aug 15;202(4):473-7 26920678 - Sci China Life Sci. 2016 Dec;59(12 ):1270-1281 26869530 - Mult Scler. 2016 Dec;22(14 ):1821-1829 23257621 - Mult Scler. 2013 Jul;19(8):1052-9 22302543 - Neurology. 2012 Feb 28;78(9):665-71; discussion 669 8057110 - J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):897-902 27147513 - J Neurol. 2016 Jul;263(7):1349-60 26185777 - Neurol Neuroimmunol Neuroinflamm. 2015 Jul 02;2(4):e131 28615429 - Neurology. 2017 Jul 18;89(3):269-278 26498263 - Mult Scler. 2016 Jun;22(7):964-8 24425068 - JAMA Neurol. 2014 Mar;71(3):276-83 22914827 - Neurology. 2012 Sep 18;79(12):1273-7 25364774 - Neurol Neuroimmunol Neuroinflamm. 2014 Oct 29;1(4):e40 26708342 - Autoimmun Rev. 2016 Apr;15(4):307-24 27458601 - Neurol Neuroimmunol Neuroinflamm. 2016 Jun 30;3(5):e257 21169067 - Clin Immunol. 2011 Mar;138(3):247-54 26209592 - Mult Scler. 2016 Mar;22(3):312-9 24424177 - Autoimmun Rev. 2014 Apr-May;13(4-5):539-45 19076824 - Clin Exp Immunol. 2009 Jan;155(1):1-15 26593750 - Eur J Neurol. 2016 Mar;23 (3):580-7 23658379 - Neurology. 2013 Jun 11;80(24):2194-200 12538397 - Brain. 2003 Feb;126(Pt 2):276-84 28364548 - Brain. 2017 Mar 1;140(3):617-627 28770374 - J Neurol. 2017 Sep;264(9):1945-1955 23997151 - Neurology. 2013 Oct 1;81(14):1197-204 24871874 - Neurology. 2014 Jul 15;83(3):278-86 26800711 - J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1257-1259 25340056 - Neurol Neuroimmunol Neuroinflamm. 2014 May 22;1(1):e12 28684532 - J Neurol Neurosurg Psychiatry. 2017 Oct;88(10 ):811-817 21387374 - Ann Neurol. 2011 Feb;69(2):292-302 27793206 - J Neuroinflammation. 2016 Sep 27;13(1):280 26516628 - Neurol Neuroimmunol Neuroinflamm. 2015 Oct 15;2(6):e163 27128728 - Neuropediatrics. 2016 Aug;47(4):245-52 26092914 - Neurology. 2015 Jul 14;85(2):177-89 25889963 - J Neuroinflammation. 2015 Mar 08;12:46 23572237 - Mult Scler. 2013 Sep;19(10):1261-7 19687098 - J Immunol. 2009 Sep 15;183(6):4067-76 26668077 - J Neurol. 2016 Feb;263(2):370-9 26041801 - Mult Scler. 2016 Feb;22(2):174-84
References_xml	– volume: 126 start-page: 276 year: 2003 end-page: 284 ident: CR36 article-title: Chronic relapsing inflammatory optic neuropathy (CRION) publication-title: Brain doi: 10.1093/brain/awg045 – volume: 364 start-page: 2106 year: 2004 end-page: 2112 ident: CR1 article-title: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis publication-title: Lancet doi: 10.1016/S0140-6736(04)17551-X – volume: 1 start-page: e12 year: 2014 ident: CR58 article-title: Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000012 – volume: 2 start-page: e89 year: 2015 ident: CR19 article-title: MOG cell-based assay detects non-MS patients with inflammatory neurologic disease publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000089 – volume: 83 start-page: 278 year: 2014 end-page: 286 ident: CR35 article-title: Defining the clinical course of multiple sclerosis: the 2013 revisions publication-title: Neurology doi: 10.1212/WNL.0000000000000560 – volume: 19 start-page: 1261 year: 2013 end-page: 1267 ident: CR38 article-title: International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions publication-title: Mult Scler doi: 10.1177/1352458513484547 – volume: 2 start-page: 2055217316675634 year: 2016 ident: CR41 article-title: Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India publication-title: Mult Scler J Exp Transl Clin – volume: 1 start-page: e40 year: 2014 ident: CR43 article-title: Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000040 – volume: 87 start-page: 1257 year: 2016 end-page: 1259 ident: CR52 article-title: Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2015-312676 – volume: 13 start-page: 539 year: 2014 end-page: 545 ident: CR37 article-title: Diagnosis and classification of autoimmune optic neuropathy publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2014.01.009 – volume: 155 start-page: 1 year: 2009 end-page: 15 ident: CR42 article-title: The role of infections in autoimmune disease publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2008.03834.x – volume: 22 start-page: 470 year: 2016 end-page: 482 ident: CR44 article-title: Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis publication-title: Mult Scler doi: 10.1177/1352458515593406 – volume: 79 start-page: 1273 year: 2012 end-page: 1277 ident: CR15 article-title: Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype publication-title: Neurology doi: 10.1212/WNL.0b013e31826aac4e – volume: 80 start-page: 2194 year: 2013 end-page: 2200 ident: CR6 article-title: Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity publication-title: Neurology doi: 10.1212/WNL.0b013e318296e917 – volume: 3 start-page: e257 year: 2016 ident: CR27 article-title: Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000257 – year: 2017 ident: CR49 article-title: MOG antibody-related disorders: common features and uncommon presentations publication-title: J Neurol – volume: 47 start-page: 245 year: 2016 end-page: 252 ident: CR51 article-title: Myelin oligodendrocyte glycoprotein-associated pediatric central nervous system demyelination: clinical course, neuroimaging findings, and response to therapy publication-title: Neuropediatrics doi: 10.1055/s-0036-1583184 – volume: 57 start-page: 897 year: 1994 end-page: 902 ident: CR39 article-title: Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.57.8.897 – volume: 6 start-page: 383 year: 2010 end-page: 392 ident: CR3 article-title: AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2010.72 – volume: 59 start-page: 1270 year: 2016 end-page: 1281 ident: CR23 article-title: Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD publication-title: Sci China Life Sci doi: 10.1007/s11427-015-4997-y – volume: 263 start-page: 370 year: 2016 end-page: 379 ident: CR48 article-title: Isolated new onset ‘atypical’ optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up publication-title: J Neurol doi: 10.1007/s00415-015-7983-1 – volume: 140 start-page: 617 year: 2017 end-page: 627 ident: CR55 article-title: Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis publication-title: Brain doi: 10.1093/brain/aww350 – volume: 66 start-page: 833 year: 2009 end-page: 842 ident: CR8 article-title: Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease publication-title: Ann Neurol doi: 10.1002/ana.21916 – volume: 23 start-page: 580 year: 2016 end-page: 587 ident: CR24 article-title: Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in The Netherlands publication-title: Eur J Neurol doi: 10.1111/ene.12898 – volume: 87 start-page: 897 year: 2016 end-page: 905 ident: CR28 article-title: Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2015-311743 – volume: 12 start-page: 46 year: 2015 ident: CR20 article-title: Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype publication-title: J Neuroinflammation doi: 10.1186/s12974-015-0256-1 – volume: 183 start-page: 4067 year: 2009 end-page: 4076 ident: CR10 article-title: Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis publication-title: J Immunol doi: 10.4049/jimmunol.0801888 – volume: 82 start-page: 474 year: 2014 end-page: 481 ident: CR17 article-title: Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders publication-title: Neurology doi: 10.1212/WNL.0000000000000101 – volume: 2 start-page: 295 year: 2015 end-page: 301 ident: CR18 article-title: Histopathology and clinical course of MOG-antibody-associated encephalomyelitis publication-title: Ann Clin Transl Neurol doi: 10.1002/acn3.164 – volume: 69 start-page: 752 year: 2012 end-page: 756 ident: CR9 article-title: Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis publication-title: Arch Neurol doi: 10.1001/archneurol.2011.2956 – volume: 22 start-page: 312 year: 2016 end-page: 319 ident: CR47 article-title: Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications publication-title: Mult Scler doi: 10.1177/1352458515591071 – volume: 21 start-page: 866 year: 2015 end-page: 874 ident: CR57 article-title: Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease publication-title: Mult Scler doi: 10.1177/1352458514555785 – year: 2017 ident: CR11 article-title: Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome publication-title: Neurology – volume: 263 start-page: 1349 year: 2016 end-page: 1360 ident: CR26 article-title: Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes publication-title: J Neurol doi: 10.1007/s00415-016-8147-7 – volume: 77 start-page: 580 year: 2011 end-page: 588 ident: CR13 article-title: Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis publication-title: Neurology doi: 10.1212/WNL.0b013e318228c0b1 – volume: 69 start-page: 292 year: 2011 end-page: 302 ident: CR34 article-title: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria publication-title: Ann Neurol doi: 10.1002/ana.22366 – volume: 30 start-page: 295 year: 2017 end-page: 301 ident: CR33 article-title: Myelin oligodendrocyte glycoprotein antibodies: how clinically useful are they? publication-title: Curr Opin Neurol doi: 10.1097/WCO.0000000000000446 – volume: 15 start-page: 307 year: 2016 end-page: 324 ident: CR45 article-title: Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2015.12.004 – year: 2017 ident: CR50 article-title: Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases publication-title: J Neurol Neurosurg Psychiatry – volume: 22 start-page: 1821 year: 2016 end-page: 1829 ident: CR22 article-title: Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases publication-title: Mult Scler doi: 10.1177/1352458516631038 – volume: 2 start-page: e131 year: 2015 ident: CR46 article-title: Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000131 – volume: 2 start-page: e163 year: 2015 ident: CR54 article-title: Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000163 – volume: 13 start-page: 279 year: 2016 ident: CR29 article-title: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin publication-title: J Neuroinflammation doi: 10.1186/s12974-016-0717-1 – volume: 8 start-page: 184 year: 2011 ident: CR12 article-title: Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders publication-title: J Neuroinflammation doi: 10.1186/1742-2094-8-184 – volume: 19 start-page: 1052 year: 2013 end-page: 1059 ident: CR56 article-title: Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica publication-title: Mult Scler doi: 10.1177/1352458512470310 – volume: 13 start-page: 280 year: 2016 ident: CR30 article-title: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome publication-title: J Neuroinflammation doi: 10.1186/s12974-016-0718-0 – volume: 24 start-page: 875 year: 2017 end-page: 879 ident: CR32 article-title: Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients publication-title: Eur J Neurol doi: 10.1111/ene.13315 – volume: 81 start-page: 1197 year: 2013 end-page: 11204 ident: CR4 article-title: Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica publication-title: Neurology doi: 10.1212/WNL.0b013e3182a6cb5c – volume: 89 start-page: 269 year: 2017 end-page: 278 ident: CR31 article-title: Diagnostic algorithm for relapsing acquired demyelinating syndromes in children publication-title: Neurology doi: 10.1212/WNL.0000000000004117 – volume: 78 start-page: 665 year: 2012 end-page: 671 ident: CR5 article-title: Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays publication-title: Neurology doi: 10.1212/WNL.0b013e318248dec1 – volume: 138 start-page: 247 year: 2011 end-page: 254 ident: CR40 article-title: Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases publication-title: Clin Immunol doi: 10.1016/j.clim.2010.11.013 – volume: 85 start-page: 177 year: 2015 end-page: 189 ident: CR7 article-title: International consensus diagnostic criteria for neuromyelitis optica spectrum disorders publication-title: Neurology doi: 10.1212/WNL.0000000000001729 – volume: 22 start-page: 964 year: 2016 end-page: 968 ident: CR25 article-title: The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients publication-title: Mult Scler doi: 10.1177/1352458515614093 – volume: 2 start-page: e62 year: 2015 ident: CR53 article-title: Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000062 – volume: 202 start-page: 473 year: 2005 end-page: 477 ident: CR2 article-title: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel publication-title: J Exp Med doi: 10.1084/jem.20050304 – volume: 22 start-page: 174 year: 2016 end-page: 184 ident: CR21 article-title: Clinical and MRI phenotype of children with MOG antibodies publication-title: Mult Scler doi: 10.1177/1352458515587751 – volume: 103 start-page: 19057 year: 2006 end-page: 19062 ident: CR14 article-title: Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0607242103 – volume: 71 start-page: 276 year: 2014 end-page: 283 ident: CR16 article-title: Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2013.5857 – volume: 81 start-page: 1197 year: 2013 ident: 8635_CR4 publication-title: Neurology doi: 10.1212/WNL.0b013e3182a6cb5c – volume: 24 start-page: 875 year: 2017 ident: 8635_CR32 publication-title: Eur J Neurol doi: 10.1111/ene.13315 – year: 2017 ident: 8635_CR49 publication-title: J Neurol doi: 10.1007/s00415-017-8583-z – volume: 66 start-page: 833 year: 2009 ident: 8635_CR8 publication-title: Ann Neurol doi: 10.1002/ana.21916 – volume: 30 start-page: 295 year: 2017 ident: 8635_CR33 publication-title: Curr Opin Neurol doi: 10.1097/WCO.0000000000000446 – year: 2017 ident: 8635_CR11 publication-title: Neurology doi: 10.1212/WNL.0000000000004312 – volume: 22 start-page: 174 year: 2016 ident: 8635_CR21 publication-title: Mult Scler doi: 10.1177/1352458515587751 – volume: 19 start-page: 1261 year: 2013 ident: 8635_CR38 publication-title: Mult Scler doi: 10.1177/1352458513484547 – volume: 364 start-page: 2106 year: 2004 ident: 8635_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(04)17551-X – volume: 183 start-page: 4067 year: 2009 ident: 8635_CR10 publication-title: J Immunol doi: 10.4049/jimmunol.0801888 – volume: 1 start-page: e40 year: 2014 ident: 8635_CR43 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000040 – volume: 78 start-page: 665 year: 2012 ident: 8635_CR5 publication-title: Neurology doi: 10.1212/WNL.0b013e318248dec1 – volume: 22 start-page: 1821 year: 2016 ident: 8635_CR22 publication-title: Mult Scler doi: 10.1177/1352458516631038 – volume: 22 start-page: 964 year: 2016 ident: 8635_CR25 publication-title: Mult Scler doi: 10.1177/1352458515614093 – volume: 13 start-page: 280 year: 2016 ident: 8635_CR30 publication-title: J Neuroinflammation doi: 10.1186/s12974-016-0718-0 – volume: 3 start-page: e257 year: 2016 ident: 8635_CR27 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000257 – volume: 21 start-page: 866 year: 2015 ident: 8635_CR57 publication-title: Mult Scler doi: 10.1177/1352458514555785 – volume: 71 start-page: 276 year: 2014 ident: 8635_CR16 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2013.5857 – volume: 89 start-page: 269 year: 2017 ident: 8635_CR31 publication-title: Neurology doi: 10.1212/WNL.0000000000004117 – volume: 2 start-page: e89 year: 2015 ident: 8635_CR19 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000089 – volume: 138 start-page: 247 year: 2011 ident: 8635_CR40 publication-title: Clin Immunol doi: 10.1016/j.clim.2010.11.013 – volume: 13 start-page: 539 year: 2014 ident: 8635_CR37 publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2014.01.009 – volume: 85 start-page: 177 year: 2015 ident: 8635_CR7 publication-title: Neurology doi: 10.1212/WNL.0000000000001729 – volume: 126 start-page: 276 year: 2003 ident: 8635_CR36 publication-title: Brain doi: 10.1093/brain/awg045 – volume: 57 start-page: 897 year: 1994 ident: 8635_CR39 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.57.8.897 – volume: 59 start-page: 1270 year: 2016 ident: 8635_CR23 publication-title: Sci China Life Sci doi: 10.1007/s11427-015-4997-y – volume: 2 start-page: 295 year: 2015 ident: 8635_CR18 publication-title: Ann Clin Transl Neurol doi: 10.1002/acn3.164 – volume: 87 start-page: 897 year: 2016 ident: 8635_CR28 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2015-311743 – volume: 22 start-page: 470 year: 2016 ident: 8635_CR44 publication-title: Mult Scler doi: 10.1177/1352458515593406 – volume: 103 start-page: 19057 year: 2006 ident: 8635_CR14 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0607242103 – volume: 80 start-page: 2194 year: 2013 ident: 8635_CR6 publication-title: Neurology doi: 10.1212/WNL.0b013e318296e917 – volume: 82 start-page: 474 year: 2014 ident: 8635_CR17 publication-title: Neurology doi: 10.1212/WNL.0000000000000101 – year: 2017 ident: 8635_CR50 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2017-315998 – volume: 87 start-page: 1257 year: 2016 ident: 8635_CR52 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2015-312676 – volume: 2 start-page: 205521731667563 year: 2016 ident: 8635_CR41 publication-title: Mult Scler J Exp Transl Clin – volume: 15 start-page: 307 year: 2016 ident: 8635_CR45 publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2015.12.004 – volume: 2 start-page: e131 year: 2015 ident: 8635_CR46 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000131 – volume: 1 start-page: e12 year: 2014 ident: 8635_CR58 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000012 – volume: 77 start-page: 580 year: 2011 ident: 8635_CR13 publication-title: Neurology doi: 10.1212/WNL.0b013e318228c0b1 – volume: 202 start-page: 473 year: 2005 ident: 8635_CR2 publication-title: J Exp Med doi: 10.1084/jem.20050304 – volume: 79 start-page: 1273 year: 2012 ident: 8635_CR15 publication-title: Neurology doi: 10.1212/WNL.0b013e31826aac4e – volume: 140 start-page: 617 year: 2017 ident: 8635_CR55 publication-title: Brain doi: 10.1093/brain/aww350 – volume: 2 start-page: e163 year: 2015 ident: 8635_CR54 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000163 – volume: 22 start-page: 312 year: 2016 ident: 8635_CR47 publication-title: Mult Scler doi: 10.1177/1352458515591071 – volume: 69 start-page: 752 year: 2012 ident: 8635_CR9 publication-title: Arch Neurol doi: 10.1001/archneurol.2011.2956 – volume: 155 start-page: 1 year: 2009 ident: 8635_CR42 publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2008.03834.x – volume: 263 start-page: 370 year: 2016 ident: 8635_CR48 publication-title: J Neurol doi: 10.1007/s00415-015-7983-1 – volume: 83 start-page: 278 year: 2014 ident: 8635_CR35 publication-title: Neurology doi: 10.1212/WNL.0000000000000560 – volume: 6 start-page: 383 year: 2010 ident: 8635_CR3 publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2010.72 – volume: 23 start-page: 580 year: 2016 ident: 8635_CR24 publication-title: Eur J Neurol doi: 10.1111/ene.12898 – volume: 263 start-page: 1349 year: 2016 ident: 8635_CR26 publication-title: J Neurol doi: 10.1007/s00415-016-8147-7 – volume: 69 start-page: 292 year: 2011 ident: 8635_CR34 publication-title: Ann Neurol doi: 10.1002/ana.22366 – volume: 13 start-page: 279 year: 2016 ident: 8635_CR29 publication-title: J Neuroinflammation doi: 10.1186/s12974-016-0717-1 – volume: 47 start-page: 245 year: 2016 ident: 8635_CR51 publication-title: Neuropediatrics doi: 10.1055/s-0036-1583184 – volume: 19 start-page: 1052 year: 2013 ident: 8635_CR56 publication-title: Mult Scler doi: 10.1177/1352458512470310 – volume: 2 start-page: e62 year: 2015 ident: 8635_CR53 publication-title: Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000000062 – volume: 8 start-page: 184 year: 2011 ident: 8635_CR12 publication-title: J Neuroinflammation doi: 10.1186/1742-2094-8-184 – volume: 12 start-page: 46 year: 2015 ident: 8635_CR20 publication-title: J Neuroinflammation doi: 10.1186/s12974-015-0256-1 – reference: 20033986 - Ann Neurol. 2009 Dec;66(6):833-42 – reference: 28364548 - Brain. 2017 Mar 1;140(3):617-627 – reference: 26920678 - Sci China Life Sci. 2016 Dec;59(12 ):1270-1281 – reference: 28615429 - Neurology. 2017 Jul 18;89(3):269-278 – reference: 25815356 - Ann Clin Transl Neurol. 2015 Mar;2(3):295-301 – reference: 26708342 - Autoimmun Rev. 2016 Apr;15(4):307-24 – reference: 19687098 - J Immunol. 2009 Sep 15;183(6):4067-76 – reference: 22371853 - Arch Neurol. 2012 Jun;69(6):752-6 – reference: 24415568 - Neurology. 2014 Feb 11;82(6):474-81 – reference: 26041801 - Mult Scler. 2016 Feb;22(2):174-84 – reference: 28768844 - Neurology. 2017 Aug 29;89(9):900-908 – reference: 12538397 - Brain. 2003 Feb;126(Pt 2):276-84 – reference: 22204662 - J Neuroinflammation. 2011 Dec 28;8:184 – reference: 22914827 - Neurology. 2012 Sep 18;79(12):1273-7 – reference: 17142321 - Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19057-62 – reference: 27788675 - J Neuroinflammation. 2016 Sep 26;13(1):279 – reference: 25889963 - J Neuroinflammation. 2015 Mar 08;12:46 – reference: 25340056 - Neurol Neuroimmunol Neuroinflamm. 2014 May 22;1(1):e12 – reference: 26498263 - Mult Scler. 2016 Jun;22(7):964-8 – reference: 23997151 - Neurology. 2013 Oct 1;81(14):1197-204 – reference: 8057110 - J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):897-902 – reference: 26516628 - Neurol Neuroimmunol Neuroinflamm. 2015 Oct 15;2(6):e163 – reference: 26668077 - J Neurol. 2016 Feb;263(2):370-9 – reference: 27458601 - Neurol Neuroimmunol Neuroinflamm. 2016 Jun 30;3(5):e257 – reference: 16087714 - J Exp Med. 2005 Aug 15;202(4):473-7 – reference: 26800711 - J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1257-1259 – reference: 27128728 - Neuropediatrics. 2016 Aug;47(4):245-52 – reference: 23572237 - Mult Scler. 2013 Sep;19(10):1261-7 – reference: 23658379 - Neurology. 2013 Jun 11;80(24):2194-200 – reference: 24425068 - JAMA Neurol. 2014 Mar;71(3):276-83 – reference: 28770374 - J Neurol. 2017 Sep;264(9):1945-1955 – reference: 27147513 - J Neurol. 2016 Jul;263(7):1349-60 – reference: 21387374 - Ann Neurol. 2011 Feb;69(2):292-302 – reference: 24871874 - Neurology. 2014 Jul 15;83(3):278-86 – reference: 28477397 - Eur J Neurol. 2017 Jun;24(6):875-879 – reference: 26645082 - J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):897-905 – reference: 23257621 - Mult Scler. 2013 Jul;19(8):1052-9 – reference: 28248700 - Curr Opin Neurol. 2017 Jun;30(3):295-301 – reference: 26092914 - Neurology. 2015 Jul 14;85(2):177-89 – reference: 28607742 - Mult Scler J Exp Transl Clin. 2016 Oct 24;2:2055217316675634 – reference: 21795651 - Neurology. 2011 Aug 9;77(6):580-8 – reference: 26869530 - Mult Scler. 2016 Dec;22(14 ):1821-1829 – reference: 25821844 - Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e89 – reference: 26163068 - Mult Scler. 2016 Apr;22(4):470-82 – reference: 22302543 - Neurology. 2012 Feb 28;78(9):665-71; discussion 669 – reference: 20639914 - Nat Rev Neurol. 2010 Jul;6(7):383-92 – reference: 24424177 - Autoimmun Rev. 2014 Apr-May;13(4-5):539-45 – reference: 26185777 - Neurol Neuroimmunol Neuroinflamm. 2015 Jul 02;2(4):e131 – reference: 25364774 - Neurol Neuroimmunol Neuroinflamm. 2014 Oct 29;1(4):e40 – reference: 25635259 - Neurol Neuroimmunol Neuroinflamm. 2015 Jan 22;2(1):e62 – reference: 26593750 - Eur J Neurol. 2016 Mar;23 (3):580-7 – reference: 26209592 - Mult Scler. 2016 Mar;22(3):312-9 – reference: 19076824 - Clin Exp Immunol. 2009 Jan;155(1):1-15 – reference: 27793206 - J Neuroinflammation. 2016 Sep 27;13(1):280 – reference: 21169067 - Clin Immunol. 2011 Mar;138(3):247-54 – reference: 28684532 - J Neurol Neurosurg Psychiatry. 2017 Oct;88(10 ):811-817 – reference: 15589308 - Lancet. 2004 Dec 11-17;364(9451):2106-12 – reference: 25344373 - Mult Scler. 2015 Jun;21(7):866-874
SSID	ssj0008459
Score	2.567038
Snippet	Anti-myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) recently emerged as a potential biomarker in patients with inflammatory demyelinating diseases of...
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	2420
SubjectTerms	Aquaporin 4 Central nervous system Demyelinating diseases Demyelination Glycoproteins Immunofluorescence Immunoglobulin G Immunoglobulins Laboratories Magnetic resonance imaging Medicine Medicine & Public Health Myelin Neurology Neuroradiology Neurosciences Oligodendrocyte-myelin glycoprotein Optic nerve Original Communication Spinal cord
SummonAdditionalLinks	– databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1Lb9QwEIAtKAhx4f1YKMhInEAWdvxIwgUhRAEJKg6A9hbZjtOutE3KZhdp_wK_mhnHCSwVvXCLYufhzNgeZ8bfEPJU-yY4bRomjWqYcqJmrmgEC1p46Z2wWcyf8u1jfnhYzOfl5_TDrU9hleOYGAfquvP4j_wFgqOUKpUoX51-Z5g1Cr2rKYXGRXIJ02YjOz-fTwsuXqiYLI1LxZmWWo1eTT5ARAWGrcEYDXMuU7vz0hlj82zM5F-O0zgfHVz_35bcINeSJUpfD6pzk1wI7S1y5VPytd8mPxMydEnjbszV5oTatqYfjt7RfuM8Wt1wYkCa0K6B4_WCnWxxfzvtlgtY7waEIfjtOtCj5dZ3EQkBhVjRdfWW2aQaoaYjOKF_SS2NQY74BcKKRvztHfL14O2XN-9ZytzAvJZmzXSRNXkouVcw1moZEFxncpk1teFZEHVpGylBhz2Hc6LwpUPDS-fOFjbjUsu7ZK_t2nCfUIN7iZzPlA5G1WWwwoPF42HCVcKbUs4IH-VW-YQ1x-way2oCMkdRVyDqCkVdqRl5Nl1yOjA9zqu8P0qxSt27r36LcEaeTMXQMdHbYtvQbbAOouLAQoBXvDfozvQ0ZOyjJTsj-Y5WTRUQ-r1b0i6OI_xbG1gTCbjn81H__nitfzXiwfmNeEiuZtgTYpTOPtkDlQqPyGX_Y73oV49jn_oFEMcqHQ priority: 102 providerName: ProQuest
Title	Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study
URI	https://link.springer.com/article/10.1007/s00415-017-8635-4 https://www.ncbi.nlm.nih.gov/pubmed/29063242 https://www.proquest.com/docview/1964449419 https://www.proquest.com/docview/1955073033 https://pubmed.ncbi.nlm.nih.gov/PMC5688213
Volume	264
WOSCitedRecordID	wos000415632900009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1432-1459 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0008459 issn: 0340-5354 databaseCode: 7X7 dateStart: 19970401 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1432-1459 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0008459 issn: 0340-5354 databaseCode: BENPR dateStart: 19970401 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: Springer Journals - Owned customDbUrl: eissn: 1432-1459 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0008459 issn: 0340-5354 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-xDSFe-B4rjMpIPIEsxbGdD94AbYAE1TRg6ltkO86o1CWoaSf1X-Cv5s5NIsoACV6iyL4ktvOz76y7-xngmXaVtzqpuExUxZUVJbdZJbjXwklnhYnD-SlnH9LJJJtO85Muj7vto917l2RYqYdkN6KGokAzXFVRS3K1A3uo7TKajaefzoblN1PhhLRIqohrqVXvyvzdK7aV0RUL82qg5C_e0qCEjm__V_PvwK3O5mSvNiC5C9d8fQ9ufOy86vfhe0cOOmch73KxumCmLtn787esXVlH9jUWbMhLWFPh_XLGL9aUyc6a-Qx3tp5oD9x66dn5fO2aQP6AlSRom3LNTQcCX7KeIqF9yQwL4YzUbb9ggej2AXw5Pvr85h3vzmjgTstkyXUWV6nPI6dwVdXSE0Vdksq4KpMo9qLMTSUlotVFWCYyl1sysXRqTWbiSGq5D7t1U_sDYAllDVkXK-0TVebeCIe2jUPVqoRLcjmCqP9ZhesIzOkcjXkxUC-HMS5wjAsa40KN4PnwyLcNe8ffhA97BBTdRG4L4itTKlciH8HToRqnIPlVTO2bFckQKRzaAtjEhxvADF8jNn2yWUeQbkFpECB67-2aevY10HzrBHc_At_5ogfUT836Uyce_ZP0Y7gZEyJDeM4h7CLC_BO47i6Xs3Yxhp10moZrNoa910eTk9NxmGs_ABy5IuY
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VBQGX8qYLBYwEF5BFHNt5ICGEgNJVtysOBe0tJI5TVtomZR-g_AV-DL-RGecBS0VvPXCL7EliO5_HM_H4G4DH2hQ200HBZaAKrjKR8ywqBLdaGGkykfouf8qnUTgeR5NJ_GEDfnZnYSisstOJTlHnlaF_5M-JOEqpWIn41clXTlmjaHe1S6HRwGLf1t_RZVu8HL7F7_vE93ffHb7Z421WAW60DJZcR34R2tgzCvWAlpZI1YJQ-kUeeL4VeZwWUuL4Gg_LRGTijIwCHWZplPqeyxKBKv8C6vGQQsjCSe_geZFyydk8qTyupVbdLqrXkJYKCpPDNQHXeK7W18FTxu3pGM2_Nmrd-rd79X8buWuw1Vra7HUzNa7Dhi1vwKWDNpbgJvxoKVFnzJ02na-OWVrmbHj0ni1WmSGvAgsayhZWFXi9nPLjms7vs2o2RX_eEtmDqZeWHc1qUznKC6wkwazKa5620Lc564ghFi9YylwQJ424nTNH73sLPp7LSNyGzbIq7TawgM5KZcZX2gYqj20qDFp0Bg0KJUwQywF4HU4S09K2U_aQWdITTjtoJQithKCVqAE87W85aThLzhLe6VCTtOprkfyGzAAe9dWoeGg3KS1ttSIZosJDCwibeKfBav82yiFAlvoAwjUU9wJEar5eU06_OHJzHaDPJ_CZzzq8_9Gsf3Xi7tmdeAiX9w4PRsloON6_B1d8moUuImkHNhFe9j5cNN-W08X8gZvPDD6f9zT4BaQEhEY
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VBVVceD8WChgJLiCrcWzngYQQoiysWlY9ANpbSBynXWmbtPsA5S_wk_h1zDgPWCp664FbFHs3jveb8cx6_H0AT7UpbKaDgstAFVxlIudZVAhutTDSZCL1nX7Kl_1wPI4mk_hgA352Z2GorLLzic5R55Wh_8h3iDhKqViJeKdoyyIOdoevT045KUjRTmsnp9FAZM_W3zF9W7wa7eJv_cz3h-8-vf3AW4UBbrQMllxHfhHa2DMKfYKWlgjWglD6RR54vhV5nBZS4lwbD--JyMQZBQg6zNIo9T2nGIHu_1IoZUiyEeGkT_a8SDmhNk8qj2upVbej6jUEpoJK5nB9wPWeq_U18Uyge7Ze869NW7cWDq_9z7N4Ha62ETh705jMDdiw5U3Y-tjWGNyCHy1V6oy5U6jz1TFLy5yNDt-zxSozlG3gjYbKhVUFXi-n_Limc_2smk0xz7dEAmHqpWWHs9pUjgoDG6ljVuU1T1uTsDnrCCMWL1nKXHEnzb6dM0f7exs-X8hM3IHNsirtPWABnaHKjK-0DVQe21QYjPQMBhpKmCCWA_A6zCSmpXMnVZFZ0hNRO5glCLOEYJaoATzvP3LScJmc13m7Q1DSurVF8hs-A3jSN6NDol2mtLTVivoQRR5GRjjEuw1u-6eRtgBF8AMI1xDddyCy8_WWcnrkSM91gLmgwO980WH_j2H96yXun_8Sj2EL0Z_sj8Z7D-CKTwbpCpW2YRPRZR_CZfNtOV3MHznTZvD1oq3gF8W7jPo
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+spectrum+and+IgG+subclass+analysis+of+anti-myelin+oligodendrocyte+glycoprotein+antibody-associated+syndromes%3A+a+multicenter+study&rft.jtitle=Journal+of+neurology&rft.au=Mariotto%2C+Sara&rft.au=Ferrari%2C+Sergio&rft.au=Monaco%2C+Salvatore&rft.au=Benedetti%2C+Maria+Donata&rft.date=2017-12-01&rft.issn=1432-1459&rft.eissn=1432-1459&rft.volume=264&rft.issue=12&rft.spage=2420&rft_id=info:doi/10.1007%2Fs00415-017-8635-4&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-5354&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-5354&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-5354&client=summon